When corruption occurs in public health procurement, the quality of health services decreases and citizens end up paying the deficit, partly as a result of funds being misallocated. However, corruption in the health system can also result in medicine shortages, inflated drug prices and the infiltration of falsified and substandard medicines into the health system.
Such issues will continue to disproportionately affect the users of public healthcare systems, particularly in low and middle-income countries, where resources are already strained. This is exacerbated by the escalating challenge of a rapidly ageing population, which in turn increases the prevalence of non-communicable diseases, and with it, the financial burden of procuring medicines to treat such diseases. Furthermore, the unpredictability of major health crises also serve to further undermine the future stability of global healthcare. 1
However, healthcare providers, community organisations and the private sector have, through open contracting, the ability to drive significant changes to the structure of public health financing, facilitating its stabilisation, improving its efficiency and ultimately saving lives.
Read about corruption in health from the point of view of real people here